G&L welcomes Arun Luckychetty as Vice President, Global Head of Business Development

G&L Scientific is pleased to announce that Arun Luckychetty has joined the company as Vice President and Global Head of Business Development. 

With an impressive 22 years of experience in the life sciences industry, Arun’s leadership and expertise in regulatory affairs, pharmacovigilance, clinical development, and commercial operations will help propel G&L Scientific to new heights.

In his new role, Arun will lead strategic growth initiatives to expand the company’s global presence, strengthen leadership in regulatory, quality, and market access solutions, and build relationships with pharmaceutical, biotechnology, and medical device companies worldwide. 

Arun will play a critical role in shaping G&L Scientific’s efforts to accelerate product development, ensure regulatory compliance, and optimize commercialization strategies for clients.

Arun has held leadership positions at several renowned organizations including RxLogix, Genpact, Freyr Life Sciences, HCL America, Parexel International, and Wyeth Pharmaceuticals, where he drove significant growth and led global teams to deliver innovative solutions. His proven ability to scale operations and develop technology-enabled solutions will support G&L Scientific’s mission of delivering excellence to clients in the life sciences sector.

Speaking about Arun’s appointment, Stephen Loughrey, CEO of G&L Scientific, shared, “We are delighted to welcome Arun to G&L Scientific. His wealth of experience, leadership skills, and passion for digital transformation make him an ideal fit for our organization. We look forward to his contributions in furthering our mission and driving innovative solutions for our clients around the globe.”

Stephen Loughrey, added, “Arun’s expertise in driving business growth and his ability to innovate will be integral to G&L’s commitment to supporting the pharmaceutical, biopharmaceutical, and biotechnology industries globally.

Following the recent launch of our Integrated Product Development and Market Access Platform, Arun will play a vital role in bringing our services to clients and delivering impactful solutions that ultimately benefit patients worldwide.”

As part of his role, Arun will work closely with the G&L Scientific team to guide clients through complex regulatory landscapes and maximize the value of their assets, ultimately advancing global healthcare.